Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Cash flows from operating activities:
Net loss	$ (7,554,305)	$ (4,296,561)
Adjustments to reconcile net loss to net cash provided by operating activites
Depreciation and amortization	462,000	388,000
Amortization of ROU asset	501,000	470,771
Realized currency translation gain	(92,282)	0
Gain on forgiveness of PPP Funding	0	(1,047,700)
Gain on sale of building	(3,356,794)	0
Provision for losses on accounts receivable	39,540	20,666
Provision for losses on inventories	0	(40,382)
Impairment of Note Receivable	95,000	350,000
Deconsolidation of disposed entities	10,014,537	2,520,616
Change in assets and liabilities:
Accounts receivable	(1,673,283)	3,991,366
Inventories	(604,327)	1,827,506
Prepaid expenses and other assets	131,884	(249,373)
Change in ROU liability	(501,000)	(470,771)
Trade payables	(1,172,867)	(1,361,051)
Accrued liabilities	964	(780,534)
Net cash provided by (used in) operating activities	(3,709,933)	1,322,452
Cash flows from investing activities:
Purchases of property, plant and equipment	(122,000)	(115,080)
Proceeds from Sale of building	3,500,000	0
Net cash provided by (used in) investing activities	3,378,000	(115,080)
Cash flows from financing activities:
Repayment of debt and revolving line of credit	(8,283,898)	(10,158,387)
Proceeds from advance from investor	0	1,500,000
Proceeds from issuance of preferred stock	3,000,000	5,426,601
Cash paid for stock issuance costs	0	(1,024,313)
Cash paid for deferred financing fees	85,492	(64,887)
Proceeds from PPP	0	1,047,700
Proceeds from issuance of long-term debt and revolving line of credit	5,995,339	876,791
Net cash used in financing activities	625,949	(2,266,721)
Effect of exchange rate changes on cash	(550,365)	536,430
Net decrease in cash and cash equivalents	(256,349)	(522,919)
Cash and cash equivalents at beginning of period	322,179	845,098
Cash and cash equivalents at end of period	65,830	322,179
Supplemental disclosure of cash flow information:
Cash payments for interest	491,000	1,167,029
Accrued dividend and accretion on Series A and B Preferred Stock	536,000	412,000
Issuance of Placement agent warrants in connection with Series A Preferred offering	0	919,000
Stock issued	3,000,000	0
Cash receipts for tax refund	206,000	0
Amortization of beneficial conversion feature and deemed dividend on Series C and D Preferred stock	2,990,000	3,968,000
Stock Placement Agent [Member]
Supplemental disclosure of cash flow information:
Stock issued	0	306,000
Conversion of Debt to Series A Preferred [Member]
Supplemental disclosure of cash flow information:
Conversion of accounts payable debt to Series A Preferred	$ 0	$ 478,000